Systemic lupus erythematosus is a complex and potentially fatal autoimmune disease,
characterized by autoantibody production and multi-organ damage. By a genome-wide …

Objective To study the incidence, predictors, and outcome of renal flares after successful
cyclophosphamide (CYC) treatment for diffuse proliferative glomerulonephritis (DPGN) in …

Systemic lupus erythematosus (SLE) is a prototype autoimmune disease with a strong genetic
involvement and ethnic differences. Susceptibility genes identified so far only explain a …

PURPOSE: To report the long-term outcome of diffuse proliferative lupus nephritis (DPLN)
treated with cyclophosphamide (CYC) in Chinese patients. METHODS: Patients with biopsy-…

Background Etoricoxib is a highly selective COX-2 inhibitor which was evaluated for the
treatment of rheumatoid arthritis (RA). Methods Double-blind, randomized, placebo and active …

ITGAM was recently found to be associated with systemic lupus erythematosus (SLE) in
populations of not only European ancestry, but also in Hispanic- and African-Americans, …

Objective. This study aims to identify the existence of, and relationship between autoantibody
clusters and clinical subsets in Chinese SLE patients. Methods. Data from 1928 SLE …

Systemic lupus erythematosus (SLE) is an autoimmune disease with a strong genetic
involvement. The susceptibility genes identified so far can only explain a small proportion of …

OBJECTIVE: To describe the clinical characteristics of Behçet's disease (BD) in a southern
Chinese population and compare them with those reported in other ethnic groups. METHODS…

Objectives Genetic interaction has been considered as a hallmark of the genetic
architecture of systemic lupus erythematosus (SLE). Based on two independent genome-wide …